Spatial assessment of advanced-stage diagnosis and lung cancer mortality in Brazil
Open Access
- 18 March 2022
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (3) , e0265321
Abstract
The high incidence and mortality rates make lung cancer a global public health issue. Socioeconomic conditions and the provision of health services may be associated with this reality. This study investigates the spatial distribution of advanced-stage diagnosis and mortality due to lung cancer and its association with the healthcare services supply and demographic and socioeconomic indicators in Brazil. This is an ecological study with 161 Intermediate Regions of Urban Articulation. Mortality data were extracted from the Mortality Information System, and the cases of lung cancer were obtained from the Integrator of Hospital-Based Cancer Registries from 2011 to 2015. Analyses employed Moran’s I, local indicators of spatial association, and the multivariable model. The proportion of advanced-stage diagnosis was 85.28% (95% CI 83.31–87.10) and was positively associated with the aging rate (Moran’s I 0.11; p = 0.02), per capita income (Moran’s I 0.05; p = 0.01) and negatively associated with Gini Index (Moran’s I -0.16; p = 0.01). The mean age-adjusted mortality rates was 12.82 deaths/100,000 inhabitants (SD 5.12). The age-adjusted mortality rates for lung cancer presented a positive and statistically significant spatial association with all demographic, socioeconomic and healthcare services supply indicators, except for the "density of family health teams" (Moran’s I -0.02 p = 0.28). The multivariable model for the mortality rates was constituted by the variables “Density of facilities licensed in oncology”, “Per capita income”, and “Health plan coverage”. The per capita income presented positive association and health plan coverage negative association with age-adjusted mortality rates. Both associations were statistically significant. The variable density of facilities licensed in oncology showed no significant association with age-adjusted mortality rates. There is a high proportion of advanced-stage diagnosis across the Brazilian territory and inequalities in lung cancer mortality, which are correlated with the most developed areas of the country.Keywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (Finance Code 001)
This publication has 20 references indexed in Scilit:
- High Oct4 expression: implications in the pathogenesis of neuroblastic tumoursBMC Cancer, 2019
- Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methodsInternational Journal of Cancer, 2018
- Tendências no uso de serviços de saúde médicos e odontológicos e a relação com nível educacional e posse de plano privado de saúde no Brasil, 1998-2013Cadernos de Saude Publica, 2018
- Population‐based differences in the outcome and presentation of lung cancer patients based upon racial, histologic, and economic factors in all lung patients and those with metastatic diseaseCancer Medicine, 2018
- Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countriesThe Lancet, 2018
- Survival inequalities in patients with lung cancer in France: A nationwide cohort study (the TERRITOIRE Study)PLOS ONE, 2017
- Desigualdades regionais na saúde: mudanças observadas no Brasil de 2000 a 2016Ciencia & Saude Coletiva, 2017
- Socio-economic inequalities in stage at diagnosis, and in time intervals on the lung cancer pathway from first symptom to treatment: systematic review and meta-analysisThorax, 2016
- Trends in corrected lung cancer mortality rates in Brazil and regionsRevista de Saúde Pública, 2016
- Population-based evidence of a strong decline in the prevalence of smokers in Brazil (1989-2003)2007